Tim29 is a novel subunit of the human TIM22 translocase and is involved in complex assembly and stability

  1. Yilin Kang
  2. Michael James Baker
  3. Michael Liem
  4. Jade Louber
  5. Matthew McKenzie
  6. Ishara Atukorala
  7. Ching-Seng Ang
  8. Shivakumar Keerthikumar
  9. Suresh Mathivanan
  10. Diana Stojanovski  Is a corresponding author
  1. The University of Melbourne, Australia
  2. La Trobe University, Australia
  3. Hudson Institute of Medical Research, Australia

Abstract

The TIM22 complex mediates the import of hydrophobic carrier proteins into the mitochondrial inner membrane. While the TIM22 machinery has been well characterised in yeast, the human complex remains poorly characterised. Here, we identify Tim29 (C19orf52) as a novel, metazoan-specific subunit of the human TIM22 complex. The protein is integrated into the mitochondrial inner membrane with it's C-terminus exposed to the intermembrane space. Tim29 is required for the stability of the TIM22 complex and functions in the assembly of the hTim22. Furthermore, Tim29 contacts the Translocase of the Outer Mitochondrial Membrane, TOM complex, enabling a mechanism for transport of hydrophobic carrier substrates across the aqueous intermembrane space. Identification of Tim29 highlights the significance of analysing mitochondrial import systems across phylogenetic boundaries, which can reveal novel components and mechanisms in higher organisms.

Article and author information

Author details

  1. Yilin Kang

    Department of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Michael James Baker

    Department of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Michael Liem

    Department of Biochemistry and Genetics, La Trobe University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Jade Louber

    Department of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Matthew McKenzie

    Centre for Genetic Diseases, Hudson Institute of Medical Research, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Ishara Atukorala

    Department of Biochemistry and Genetics, La Trobe University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Ching-Seng Ang

    The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. Shivakumar Keerthikumar

    Department of Biochemistry and Genetics, La Trobe University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Suresh Mathivanan

    Department of Biochemistry and Genetics, La Trobe University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  10. Diana Stojanovski

    Department of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, Australia
    For correspondence
    d.stojanovski@unimelb.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0199-3222

Funding

The authors declare that there was no funding for this work

Reviewing Editor

  1. Nikolaus Pfanner, University of Freiburg, Germany

Version history

  1. Received: May 4, 2016
  2. Accepted: August 14, 2016
  3. Accepted Manuscript published: August 24, 2016 (version 1)
  4. Version of Record published: September 8, 2016 (version 2)
  5. Version of Record updated: December 1, 2016 (version 3)

Copyright

© 2016, Kang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,660
    views
  • 575
    downloads
  • 67
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yilin Kang
  2. Michael James Baker
  3. Michael Liem
  4. Jade Louber
  5. Matthew McKenzie
  6. Ishara Atukorala
  7. Ching-Seng Ang
  8. Shivakumar Keerthikumar
  9. Suresh Mathivanan
  10. Diana Stojanovski
(2016)
Tim29 is a novel subunit of the human TIM22 translocase and is involved in complex assembly and stability
eLife 5:e17463.
https://doi.org/10.7554/eLife.17463

Share this article

https://doi.org/10.7554/eLife.17463

Further reading

    1. Biochemistry and Chemical Biology
    2. Plant Biology
    Henning Mühlenbeck, Yuko Tsutsui ... Cyril Zipfel
    Research Article

    Transmembrane signaling by plant receptor kinases (RKs) has long been thought to involve reciprocal trans-phosphorylation of their intracellular kinase domains. The fact that many of these are pseudokinase domains, however, suggests that additional mechanisms must govern RK signaling activation. Non-catalytic signaling mechanisms of protein kinase domains have been described in metazoans, but information is scarce for plants. Recently, a non-catalytic function was reported for the leucine-rich repeat (LRR)-RK subfamily XIIa member EFR (elongation factor Tu receptor) and phosphorylation-dependent conformational changes were proposed to regulate signaling of RKs with non-RD kinase domains. Here, using EFR as a model, we describe a non-catalytic activation mechanism for LRR-RKs with non-RD kinase domains. EFR is an active kinase, but a kinase-dead variant retains the ability to enhance catalytic activity of its co-receptor kinase BAK1/SERK3 (brassinosteroid insensitive 1-associated kinase 1/somatic embryogenesis receptor kinase 3). Applying hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis and designing homology-based intragenic suppressor mutations, we provide evidence that the EFR kinase domain must adopt its active conformation in order to activate BAK1 allosterically, likely by supporting αC-helix positioning in BAK1. Our results suggest a conformational toggle model for signaling, in which BAK1 first phosphorylates EFR in the activation loop to stabilize its active conformation, allowing EFR in turn to allosterically activate BAK1.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Ya-Juan Wang, Xiao-Jing Di ... Ting-Wei Mu
    Research Article Updated

    Protein homeostasis (proteostasis) deficiency is an important contributing factor to neurological and metabolic diseases. However, how the proteostasis network orchestrates the folding and assembly of multi-subunit membrane proteins is poorly understood. Previous proteomics studies identified Hsp47 (Gene: SERPINH1), a heat shock protein in the endoplasmic reticulum lumen, as the most enriched interacting chaperone for gamma-aminobutyric acid type A (GABAA) receptors. Here, we show that Hsp47 enhances the functional surface expression of GABAA receptors in rat neurons and human HEK293T cells. Furthermore, molecular mechanism study demonstrates that Hsp47 acts after BiP (Gene: HSPA5) and preferentially binds the folded conformation of GABAA receptors without inducing the unfolded protein response in HEK293T cells. Therefore, Hsp47 promotes the subunit-subunit interaction, the receptor assembly process, and the anterograde trafficking of GABAA receptors. Overexpressing Hsp47 is sufficient to correct the surface expression and function of epilepsy-associated GABAA receptor variants in HEK293T cells. Hsp47 also promotes the surface trafficking of other Cys-loop receptors, including nicotinic acetylcholine receptors and serotonin type 3 receptors in HEK293T cells. Therefore, in addition to its known function as a collagen chaperone, this work establishes that Hsp47 plays a critical and general role in the maturation of multi-subunit Cys-loop neuroreceptors.